Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Profit After Tax: 2019-2021

Historic Profit After Tax for Bright Minds Biosciences (DRUG) over the last 3 years, with Sep 2021 value amounting to -$6.8 million.

  • Bright Minds Biosciences' Profit After Tax fell 3895.34% to -$11.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$6.8 million, marking a year-over-year change of. This contributed to the annual value of -$6.8 million for FY2021, which is 2015.22% down from last year.
  • Per Bright Minds Biosciences' latest filing, its Profit After Tax stood at -$6.8 million for FY2021, which was down 2,015.22% from $357,388 recorded in FY2020.
  • Over the past 5 years, Bright Minds Biosciences' Profit After Tax peaked at $357,388 during FY2020, and registered a low of -$6.8 million during FY2021.
  • For the 3-year period, Bright Minds Biosciences' Profit After Tax averaged around -$2.1 million, with its median value being $59,638 (2019).
  • Its Profit After Tax has fluctuated over the past 5 years, first skyrocketed by 499.26% in 2020, then plummeted by 2,015.22% in 2021.
  • Bright Minds Biosciences' Profit After Tax (Yearly) stood at $59,638 in 2019, then soared by 499.26% to $357,388 in 2020, then tumbled by 2,015.22% to -$6.8 million in 2021.